Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).

New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots

News | Heart Valve Technology

Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its He ...

November 20, 2023

Team Bath Heart’s artificial heart wins top prize at international engineering & design contest

News | Artificial Heart

Heart of Gold: Bath Student Team Wins World Heart Hackathon Competition

November 20, 2023 — Student engineers from the University of Bath are on top of the world after winning an international ...

November 20, 2023

News | Artificial Heart

Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference

November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has ...

November 10, 2023

News | TCT

Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

October 26, 2023

Figure 1: A PROTECT III study analysis demonstrates that 82.5% of Impella-supported HRPCI patients have features in all three high-risk factor domains – comorbidities, complex coronary anatomy and adverse hemodynamics.

News | Heart Valve Technology

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium

October 24, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

October 24, 2023

Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation

News | Structural Heart

Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark

October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system ...

October 19, 2023

The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.

News | Heart Valve Technology

St. Joseph's Children's Hospital Implants 250th Pulmonary Valve Without Open-Heart Surgery

October 17, 2023 — The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone ...

October 17, 2023

News | Heart Failure

JACC Issues Scientific Statement Exploring Impact of dLVAD on Quality of Life for HF Patients

October 5, 2023 — A newly-issued "Scientific Statement on Durable Mechanical Circulatory Support" in the October issue ...

October 04, 2023

IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients

News | Heart Valve Technology

Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis

September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

September 20, 2023

India clinical trial commences with first 30 cases

News | Heart Valve Technology

First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 — Foldax , Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

August 02, 2023

The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)

News | Heart Valve Technology

FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

July 31, 2023 — Today, the U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 ...

July 31, 2023

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania

News | Heart Valve Technology

Allegheny General Hospital Receives Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation

July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN) ...

July 24, 2023

Novel polymeric valve aims to reduce re-operations and re-interventions

News | Pediatric Cardiology

PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial

June 13, 2023 — PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric ...

June 13, 2023

Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic valve replacement modeling.

News | Artificial Intelligence

AI for Preprocedural TAVR Modeling Gains FDA Clearance

June 9, 2023 — Dasi Simulations announced it received FDA clearance for its artificial intelligence model for ...

June 09, 2023

According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled specific Impella 5.5 with SmartAssist for purge fluid leaks that can cause pump stop and loss of support. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

News | Heart Valve Technology

Abiomed Recalls Specific Impella 5.5 with SmartAssist for Purge Fluid Leaks that Can Cause Pump Stop and Loss of Support

June 6, 2023 — According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled ...

June 06, 2023